Lixte Biotechnology
About:
Lixte Biotechnology is a clinical-stage pharmaceutical company that focuses on discovering drugs for effective cancer treatments.
Website: http://www.lixte.com
Description:
Lixte Biotechnology is a clinical-stage public pharmaceutical company that focuses on discovering drugs for more effective treatments for cancer. Lixte has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. The current drug portfolio includes inhibitors of protein phosphatases that are critical to cell division and DNA damage repair and inhibitors of protein deacetylases that regulate pathways of gene expression and protein degradation.
$10.5M
$1M to $10M
East Setauket, New York, United States
2004-01-01
eforman(AT)lixte.com
John S. Kovach
1-10
2022-04-12
Public
© 2025 bioDAO.ai